Integration of Genomics in Primary Care

American Journal of Medicine

Volumn 128, Issue 11, 2015, Pages 1251.e1-1251.e5

  Larson, Eric A ^a   Wilke, Russell A ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Biomedical informatics; Electronic medical record; Personalized medicine; Pharmacogenetics; Precision medicine

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C19; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHRONIC DISEASE; DECISION SUPPORT SYSTEM; DRUG RESPONSE; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; INVESTMENT; LIFESPAN; MANAGED CARE; MEDICAL INFORMATICS; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT RESPONSE; ORGANIZATION AND MANAGEMENT; PERSONALIZED MEDICINE; PRIMARY HEALTH CARE; PROCEDURES; UNITED STATES;

DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; GENOMICS; HUMANS; PRECISION MEDICINE; PRIMARY HEALTH CARE; UNITED STATES;

EID: 84946492447     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.05.011     Document Type: Review

References (30)

1. L.W. D'Avolio, W.R. Farwell, and L.D. Fiore Comparative effectiveness research and medical informatics Am J Med 123 12 Suppl 1 2010 Dec e32 e37
2. J.M. Pulley, J.C. Denny, J.F. Peterson, and et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project Clin Pharmacol Ther 92 1 2012 87 95
3. F.S. Collins, E.D. Green, A.E. Guttmacher, and M.S. Guyer A vision for the future of genomics research Nature 422 2003 835 847
4. F.S. Collins Exceptional opportunities in medical science: a view from the National Institutes of Health JAMA 313 2 2015 131 132
5. T.M. Teslovich, K. Musunuru, A.V. Smith, and et al. Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
6. K. Ding, K.R. Bailey, and I.J. Kullo Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record BMC Cardiovasc Disord 11 2011 66
7. I. Postmus, S. Trompet, H.A. Deshmukh, and et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL-cholesterol response to statins Nat Commun 5 2014 5068
8. L.B. Ramsey, S.G. Johnson, K.E. Caudle, and et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy Clin Pharmacol Ther 96 4 2014 423 428
9. SEARCH Collaborative Group E. Link, S. Parish, J. Armitage, and et al. SLCO1B1 variants and statin-induced myopathy - a genomewide study N Engl J Med 359 8 2008 789 799
10. J.C. Denny, and R.A. Wilke Can EMRs facilitate automated gene-based drug prescribing for cardiovascular disease? Dialog Cardiovasc Med 17 4 2012 293 300
11. D.B. Goldstein, A.C. Need, R. Singh, and S.M. Sisodiya Potential genetic causes of heterogeneity of treatment effects Am J Med 120 4 Suppl 1 2007 S21 S25
12. R. Long Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network Clin Pharmacol Ther 81 3 2007 450 454
13. R.A. Wilke, and M.E. Dolan Genetics and variable drug response JAMA 306 3 2011 306 307
14. L.J. Lesko, and I. Zineh DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA Pharmacogenomics 11 4 2010 507 512
15. M.V. Relling, and T.E. Klein CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network Clin Pharmacol Ther 89 3 2011 464 467
16. Available at: http://www.pharmgkb.org/. Accessed July 10, 2015.
17. J.L. Mega, S.L. Close, S.D. Wiviott, and et al. Cytochrome P-450 polymorphisms and response to clopidogrel N Engl J Med 360 4 2009 354 362
18. K.W. Weitzel, A.R. Elsey, T.Y. Langaee, and et al. Clinical pharmacogenetics implementation: approaches, successes, and challenges Am J Med Genet C Semin Med Genet 166C 1 2014 56 67
19. S.A. Scott, K. Sangkuhl, C.M. Stein, and et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update Clin Pharmacol Ther 94 3 2013 317 323
20. S.A. Scott, K. Sangkuhl, E.E. Gardner, and et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy Clin Pharmacol Ther 90 2 2011 328 332
21. Available at: http://www.acmg.net/. Accessed July 10, 2015.
22. ACMG Board of Directors. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing Genet Med 17 1 2015 68 69
23. S. Liu, and Y. Song Building genetic scores to predict risk of complex diseases in humans: is it possible? Diabetes 59 11 2010 2729 2731
24. G. Thanassoulis, G.M. Peloso, M.J. Pencina, and et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study Circ Cardiovasc Genet 5 1 2012 113 121
25. D. Dimmock Recommend whole genome sequencing N Engl J Med 370 25 2014 2444 2445
26. W. Burke Recommend sequencing of cancer genes only, if certain conditions are met N Engl J Med 370 25 2014 2443 2444
27. Available at: http://emerge.mc.vanderbilt.edu. Accessed July 10, 2015.
28. Available at: http://www.genome.gov/27554264/. Accessed July 10, 2015.
29. L.M. Kern, A. Edwards, and R. Kaushal The patient-centered medical home, electronic health records, and quality of care Ann Intern Med 160 11 2014 741 749
30. Available at: http://imagenetics.sanfordhealth.org/. Accessed July 10, 2015.